Glossopharyngeal and Maxillary Nerve Blocks in Adenotonsillectomy

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Regional, Adenotonsillectomy

In brief

This study aims to compare of bilateral ultrasound-guided glossopharyngeal nerve (UGGNB) and ultrasound-guided maxillary nerve (UGMNB) versus conventional multimodal analgesia for tonsillectomy operations.

Key facts

Study ID

NCT07379866

Run by

Cairo University

People needed

40

Starts

2026-01-01

Expected to finish

2026-06-01

Last updated by the study team

2026-02-02

Who can join

Age: 5 and older, up to 13. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Pediatric patients aged 5 to 13 years
• American Society of Anesthesiologists (ASA) physical status I-II scheduled for adenotonsillectomy.

You may not qualify if…

• Parents Refusal
• Cognitive impairment or developmental delays.
• Infection at injection site.
• Recent upper respiratory tract infection.
• Post-tonsillectomy bleeding, allergy to local anesthetics.
• American Society of Anesthesiologists (ASA) class III and IV.
• Morbid obesity.
• Those receiving regular analgesia within the last week before surgery.

Where it is running

• Cairo University Hospitals — Cairo, Governorate, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.